{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:28:01Z","timestamp":1794436081084,"version":"4.9.1"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["2015-1-261455"],"award-info":[{"award-number":["2015-1-261455"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["2019-64382"],"award-info":[{"award-number":["2019-64382"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.expneurol.2026.115764","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:14:37Z","timestamp":1775895277000},"page":"115764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets"],"prefix":"10.1016","volume":"402","author":[{"given":"Diana D.","family":"\u00c1lvarez-Luqu\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n R.","family":"Gonz\u00e1lez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ichikawa-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Torres-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asiel","family":"Arce-Sillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor H.","family":"Ju\u00e1rez-Vaquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara L.","family":"Miranda-Narvaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisela","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Adalid-Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.brs.2020.02.019","article-title":"Electrical stimulation of cranial nerves in cognition and disease","volume":"13","author":"Adair","year":"2020","journal-title":"Brain Stimul."},{"issue":"June","key":"10.1016\/j.expneurol.2026.115764_bb0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.03.029","article-title":"Prolonged-release melatonin in parkinsons disease patients with a poor sleep quality: a randomized trial","volume":"75","author":"Ahn","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ymthe.2017.11.015","article-title":"Selective \u03b1-Synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for parkinsons disease","volume":"26","author":"Alarc\u00f3n-Ar\u00eds","year":"2018","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat. Rev. Neurol. (Engl.)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brs.2015.11.008","article-title":"Transcutaneous cervical vagus nerve stimulation ameliorates acute ischemic injury in rats","volume":"9","author":"Ay","year":"2016","journal-title":"Brain Stimul."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115764_bb0030","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in parkinsons disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0b013e3181db8831","article-title":"Two-year outcome of vagus nerve stimulation in treatment-resistant depression","volume":"30","author":"Bajbouj","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"February","key":"10.1016\/j.expneurol.2026.115764_bb0040","article-title":"Deciphering microglia phenotypes in health and disease","volume":"84","author":"Balak","year":"2024","journal-title":"Curr. Opin. Genet. Develop. (Engl.)"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115764_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080705","article-title":"Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs","volume":"8","author":"Baptista","year":"2013","journal-title":"PLoS One"},{"issue":"April","key":"10.1016\/j.expneurol.2026.115764_bb0050","article-title":"The role of astrocytes in neuroprotection after brain stroke: potential in cell therapy","volume":"10","author":"Becerra-Calixto","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-022-03142-1","article-title":"Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells","volume":"13","author":"Bi","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"November","key":"10.1016\/j.expneurol.2026.115764_bb0060","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1016\/S0040-4039(00)89431-9","article-title":"Synthesis of 3-(Beta-D-Ribofuranosyl)-5,7-Dihydroxy-1H-Pyrazolo-4,3-d pyrimidine","volume":"no. 52","author":"Bobek","year":"1970","journal-title":"Tetrahedron Lett. (Engl.)"},{"key":"10.1016\/j.expneurol.2026.115764_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnins.2018.00049","article-title":"The vagus nerve at the interface of the microbiota-gut-brain axis","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci. (Switzerland)"},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.expneurol.2014.09.015","article-title":"The \u03b17 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-Hydroxydopamine lesions","volume":"263","author":"Bordia","year":"2015","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115764_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","article-title":"Tetracycline repurposing in neurodegeneration: focus on parkinsons disease","volume":"125","author":"Bortolanza","year":"2018","journal-title":"J. Neural Transm."},{"issue":"February","key":"10.1016\/j.expneurol.2026.115764_bb0080","article-title":"Neuroactive steroids and Parkinson\u2019s disease","volume":"22","author":"Bourque","year":"2022","journal-title":"Curr. Opin. Endocrine Metab. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","article-title":"Neuroprotective actions of sex steroids in Parkinson\u2019s disease","volume":"30","author":"Bourque","year":"2009","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yfrne.2012.02.003","article-title":"Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson\u2019s disease","volume":"33","author":"Bourque","year":"2012","journal-title":"Front. Neuroendocrinol."},{"issue":"March","key":"10.1016\/j.expneurol.2026.115764_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2018.04.005","article-title":"Repurposing sex steroids and related drugs as potential treatment for Parkinson\u2019s disease","volume":"147","author":"Bourque","year":"2019","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2026.115764_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6501031","article-title":"Mechanisms of endogenous neuroprotective effects of astrocytes in brain injury","volume":"2018","author":"Bylicky","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"20","key":"10.1016\/j.expneurol.2026.115764_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131355","article-title":"STAT6\/Arg1 promotes microglia\/macrophage efferocytosis and inflammation resolution in stroke mice","volume":"4","author":"Cai","year":"2019","journal-title":"JCI Insight"},{"issue":"June","key":"10.1016\/j.expneurol.2026.115764_bb0120","article-title":"Rapid alleviation of Parkinson\u2019s disease symptoms via electrostimulation of intrinsic auricular muscle zones","volume":"11","author":"Cakmak","year":"2017","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115764_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4318416","article-title":"Genetic variants in SNCA and the risk of sporadic Parkinson\u2019s disease and clinical outcomes: a review","volume":"2017","author":"Camp\u00ealo","year":"2017","journal-title":"Parkinson\u2019s Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0130","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.18632\/aging.102927","article-title":"Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson\u2019s disease models","volume":"12","author":"Castelli","year":"2020","journal-title":"Aging"},{"issue":"March","key":"10.1016\/j.expneurol.2026.115764_bb0135","article-title":"Progesterone exerts a neuroprotective action in a Parkinson\u2019s disease human cell model through membrane progesterone receptor \u03b1 (mPR\u03b1\/PAQR7)","volume":"14","author":"Castelnovo","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-2473-5","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson\u2019s disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115764_bb0145","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/acschemneuro.5b00026","article-title":"Donepezil regulates 1-Methyl-4-Phenylpyridinium-induced microglial polarization in Parkinson\u2019s disease","volume":"6","author":"Chen","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11481-017-9732-y","article-title":"TGF-\u03921 neuroprotection via inhibition of microglial activation in a rat model of Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2017","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12264-017-0177-3","article-title":"Potassium channels: a potential therapeutic target for Parkinson\u2019s disease","volume":"34","author":"Chen","year":"2018","journal-title":"Neurosci. Bull. (Singapore)"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0160","first-page":"1051","article-title":"Clinical potential and current progress of mesenchymal stem cells for Parkinson\u2019s disease: a systematic review","volume":"41","author":"Chen","year":"2020","journal-title":"Neurol. Sci. Offl. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol.(Italy)"},{"issue":"S1","key":"10.1016\/j.expneurol.2026.115764_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jnc.13062","article-title":"Microglia and neuroprotection","volume":"136","author":"Chen","year":"2015","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0170","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/ijms21041227","article-title":"Probiotic properties and neuroprotective effects of Lactobacillus Buchneri KU200793 isolated from Korean fermented foods","volume":"21","author":"Cheon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0175","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1111\/ejn.15324","article-title":"Movement of prion-like \u0391-synuclein along the gut\u2013brain axis in Parkinson\u2019s disease: a potential target of curcumin treatment","volume":"54","author":"Chetty","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55885-2","article-title":"Parkinson\u2019s disease recovery by GM1 oligosaccharide treatment in the b4galnt1+\/\u2212 mouse model","volume":"9","author":"Chiricozzi","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0185","first-page":"171","article-title":"Vagus nerve stimulation attenuates myocardial ischemia\/reperfusion injury by inhibiting the expression of interleukin-17A","volume":"11","author":"Chunfeng","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-015-0200-8","article-title":"PGC-1\u03b1 activity in nigral dopamine neurons determines vulnerability to \u03b1-synuclein","volume":"3","author":"Ciron","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115764_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048925","article-title":"Pgc-1\u03b1 overexpression downregulates pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf","volume":"7","author":"Clark","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0200","article-title":"Il-10 signaling reduces survival in mouse models of synucleinopathy","volume":"7","author":"Cockey","year":"2021","journal-title":"Npj Parkinson\u2019s Dis."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0205","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1210\/en.2013-2158","article-title":"Transient neuroprotection by SRY upregulation in dopamine cells following injury in males","volume":"155","author":"Czech","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2026.115764_bb0210","doi-asserted-by":"crossref","first-page":"1231706","DOI":"10.3389\/fragi.2023.1231706","article-title":"The dual face of microglia (M1\/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases","volume":"4","author":"Darwish","year":"2023","journal-title":"Front. Aging (Switzerland)"},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2018.10.038","article-title":"Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration","volume":"692","author":"Dhanushkodi","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.18632\/aging.202181","article-title":"TRIM3 attenuates apoptosis in parkinsons disease via activating PI3K\/AKT signal pathway","volume":"13","author":"Dong","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther. (Engl.)"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0230","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Du Chu","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.29358","article-title":"Duodenal alpha-synuclein pathology and enteric gliosis in advanced Parkinson\u2019s disease","volume":"38","author":"Emmi","year":"2023","journal-title":"Movement Disord. Offl.J. Movement Disord. Soc. (U. S.)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0240","first-page":"1","article-title":"The protective effects of crocin in the management of neurodegenerative diseases: a review","volume":"7","author":"Farkhondeh","year":"2018","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115764_bb0245","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.brs.2017.08.008","article-title":"Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson\u2019s disease","volume":"10","author":"Farrand","year":"2017","journal-title":"Brain Stimul."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10719-020-09920-4","article-title":"The oligosaccharide portion of ganglioside GM1 regulates mitochondrial function in neuroblastoma cells","volume":"37","author":"Fazzari","year":"2020","journal-title":"Glycoconj. J."},{"issue":"5 Suppl 1","key":"10.1016\/j.expneurol.2026.115764_bb0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/0004-282x-anp-2022-s133","article-title":"Deep brain stimulation in Parkinson\u2019s disease: state of the art and future perspectives","volume":"80","author":"Fran\u00e7a","year":"2022","journal-title":"Arquivos de Neuro-Psiquiatria (Germany)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered t regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","article-title":"Molecular genetics of Parkinson\u2019s disease: contributions and global trends","volume":"68","author":"Funayama","year":"2023","journal-title":"J. Human Genet. (England)"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0270","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2174\/1570159X15666171129100944","article-title":"Alpha-Synuclein, proteotoxicity and Parkinson\u2019s disease: search for neuroprotective therapy","volume":"16","author":"Ganguly","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0275","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther. (Engl.)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/ijms21020465","article-title":"Through reducing ROS production, IL-10 suppresses Caspase-1-dependent IL-1\u03b2 maturation, thereby preventing chronic neuroinflammation and neurodegeneration","volume":"21","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"June","key":"10.1016\/j.expneurol.2026.115764_bb0285","article-title":"Role of interleukin-10 in acute brain injuries","volume":"8","author":"Garcia","year":"2017","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0290","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27886","article-title":"Melatonin for rapid eye movement sleep behavior disorder in Parkinson\u2019s disease: a randomised controlled trial","volume":"35","author":"Gilat","year":"2019","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0295","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","article-title":"Sex differences in Parkinson\u2019s disease","volume":"35","author":"Gillies","year":"2014","journal-title":"Front. Neuroendocrinol. (U. S.)"},{"issue":"31","key":"10.1016\/j.expneurol.2026.115764_bb0300","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103425118","article-title":"Wild-type GBA1 increases the \u03b1-Synuclein tetramer\u2013monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice","volume":"118","author":"Glajch","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115764_bb0305","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/srep07834","article-title":"Integrin alpha l controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4","volume":"5","author":"Glatigny","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0315","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mt.2012.28","article-title":"Glucose regulated protein 78 diminishes \u03b1-synuclein neurotoxicity in a rat model of parkinson disease","volume":"20","author":"Gorbatyuk","year":"2012","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115764_bb0320","article-title":"Treating activated regulatory t cells with pramipexole protects human dopaminergic neurons from 6-OHDA-induced degeneration","volume":"30","author":"Guevara-Salinas","year":"2024","journal-title":"CNS Neurosci. Ther. (England)"},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0325","article-title":"Therapeutic potential of K(ATP) channels in the attenuation of Parkinson\u2019s disease pathogenesis and progression - a review","volume":"192","author":"Gundi","year":"2026","journal-title":"Neurochem. Int. (England)"},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2014.10.010","article-title":"GDNF signaling implemented by GM1 ganglioside; failure in Parkinson\u2019s disease and GM1-deficient murine model","volume":"263","author":"Hadaczek","year":"2015","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0335","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/molecules24030648","article-title":"Hesperidin as a neuroprotective agent: a review of animal and clinical evidence","volume":"24","author":"Hajialyani","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0340","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol. (England)"},{"issue":"October","key":"10.1016\/j.expneurol.2026.115764_bb0345","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2013.04.011","article-title":"Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia Nigral versus striatal delivery of AAV2-NRTN (CERE-120)","volume":"58","author":"Herzog","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115764_bb0350","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/ijms20123109","article-title":"Implications of diet and the gut microbiome in neuroinflammatory and neurodegenerative diseases","volume":"20","author":"Hirschberg","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0355","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1159\/000464388","article-title":"Treg cells protect dopaminergic neurons against MPP+ neurotoxicity via CD47-SIRPA interaction","volume":"41","author":"Huang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0360","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","article-title":"Treg cells attenuate neuroinflammation and protect neurons in a mouse model of Parkinson\u2019s disease","volume":"15","author":"Huang","year":"2020","journal-title":"J. Neuroimmune Pharmacol. Offl. J. Soc. NeuroImmune Pharmacol. (U. S.)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0365","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.26421","article-title":"Parkinsons disease derived exosomes aggravate neuropathology in <scp>SNCA<\/scp>*<scp>A53T<\/Scp> mice","volume":"92","author":"Huang","year":"2022","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0370","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1673-5374.380878","article-title":"Single-neuron neurodegeneration as a degenerative model for Parkinson\u2019s disease","volume":"19","author":"Huenchuguala","year":"2024","journal-title":"Neural Regen. Res. (India)"},{"issue":"21","key":"10.1016\/j.expneurol.2026.115764_bb0375","article-title":"A potential role of natural bioactive compounds found in food in the prevention of idiopathic Parkinson\u2019s disease","volume":"17","author":"Huenchuguala","year":"2025","journal-title":"Nutrients (Switzerland)"},{"issue":"March","key":"10.1016\/j.expneurol.2026.115764_bb0380","article-title":"Interleukin-4 protects dopaminergic neurons in vitro but is dispensable for MPTP-induced neurodegeneration in vivo","volume":"10","author":"H\u00fchner","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115764_bb0385","article-title":"The role of gut microbiota in neurodegenerative diseases: current insights and therapeutic implications","volume":"15","author":"Jain","year":"2023","journal-title":"Cureus (U. S.)"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0390","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jcyt.2014.07.013","article-title":"Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine\u2013induced apoptosis","volume":"17","author":"Jarmalavi\u010di\u016bt\u0117","year":"2015","journal-title":"Cytotherapy"},{"issue":"December","key":"10.1016\/j.expneurol.2026.115764_bb0395","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2015.10.008","article-title":"Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor\/\u03b2-endorphin pathway","volume":"102","author":"Jia","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.expneurol.2026.115764_bb0400","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s11064-018-2639-z","article-title":"Auricular vagus nerve stimulation exerts antiinflammatory effects and immune regulatory function in a 6-OHDA model of Parkinson\u2019s disease","volume":"43","author":"Jiang","year":"2018","journal-title":"Neurochem. Res."},{"issue":"May","key":"10.1016\/j.expneurol.2026.115764_bb0405","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/JIR.S163248","article-title":"A review of vagus nerve stimulation as a therapeutic intervention","volume":"11","author":"Johnson","year":"2018","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0410","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.pharep.2014.03.008","article-title":"The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson\u2019s disease","volume":"66","author":"Joniec-Maciejak","year":"2014","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0415","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jnc.14284","article-title":"Microglia modulation through external vagus nerve stimulation in a murine model of Alzheimer\u2019s disease","volume":"146","author":"Kaczmarczyk","year":"2018","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0420","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12035-013-8544-1","article-title":"Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics","volume":"49","author":"Kalani","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0425","article-title":"Comprehensive review of melatonin as a promising nutritional and nutraceutical supplement","volume":"10","author":"Kamfar","year":"2024","journal-title":"Heliyon (England)"},{"key":"10.1016\/j.expneurol.2026.115764_bb0430","doi-asserted-by":"crossref","DOI":"10.18502\/ijnl.v17i3.373","article-title":"Oxidative stress-related biomarkers in Parkinson\u2019s disease: a systematic review and meta-analysis","author":"Khan","year":"2019","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.expneurol.2026.115764_bb0435","doi-asserted-by":"crossref","DOI":"10.34172\/apb.2021.026","article-title":"Effects of medicinal plants and flavonoids on Parkinson\u2019s disease, a review on basic and clinical evidences","author":"Khazdair","year":"2020","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0440","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0b013e3181342f32","article-title":"A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results","volume":"31","author":"Kieburtz","year":"2008","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0445","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1073858418793131","article-title":"TGF\u03b21: friend or foe during recovery in encephalopathy","volume":"25","author":"Kim","year":"2018","journal-title":"Neuroscientist"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0450","article-title":"Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0455","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron (U. S.)"},{"issue":"May","key":"10.1016\/j.expneurol.2026.115764_bb0460","article-title":"Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson\u2019s disease animal model","volume":"167","author":"Kim","year":"2020","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0465","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2014.01.021","article-title":"MiR-126 contributes to Parkinson\u2019s disease by dysregulating the insulin-like growth factor\/phosphoinositide 3-kinase signaling","volume":"35","author":"Kim","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"September","key":"10.1016\/j.expneurol.2026.115764_bb0470","first-page":"1","article-title":"ROCK inhibition in models of neurodegeneration and its potential for clinical translation","volume":"189","author":"Koch","year":"2018","journal-title":"Pharmacol. Ther. (Engl.)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0475","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0480","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1083\/jcb.200407027","article-title":"TGF-\u03921 activates two distinct type I receptors in neurons","volume":"168","author":"K\u00f6nig","year":"2005","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","article-title":"Diet and the gut microbiome in patients with Parkinson\u2019s disease","volume":"10","author":"Kwon","year":"2024","journal-title":"NPJ Parkinson\u2019s Dis. (U. S.)"},{"key":"10.1016\/j.expneurol.2026.115764_bb0490","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-031-12390-0_13","article-title":"Gangliosides in neurodegenerative diseases","volume":"29","author":"Ledeen","year":"2023","journal-title":"Adv. Neurobiol. (U. S.)"},{"issue":"33","key":"10.1016\/j.expneurol.2026.115764_bb0495","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1073\/pnas.1900406116","article-title":"Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY in experimental Parkinson\u2019s disease","volume":"116","author":"Lee","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115764_bb0500","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/biomedicines9081039","article-title":"GRP78 overexpression triggers PINK1-IP3R-mediated neuroprotective mitophagy","volume":"9","author":"Leiva-Rodr\u00edguez","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0505","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12031-013-9984-9","article-title":"Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity","volume":"50","author":"Lev","year":"2013","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0510","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41531-022-00352-5","article-title":"Melatonin ameliorates Parkinson\u2019s disease via regulating microglia polarization in a ROR\u03b1-dependent pathway","volume":"8","author":"Li","year":"2022","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2026.115764_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/657086","article-title":"Exosomes: novel biomarkers for clinical diagnosis","volume":"2015","author":"Lin","year":"2015","journal-title":"Sci. World J."},{"key":"10.1016\/j.expneurol.2026.115764_bb0520","article-title":"Calcium channel blockers and Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"17","author":"Lin","year":"2024","journal-title":"Ther. Adv. Neurol. Disord. (England)"},{"issue":"March","key":"10.1016\/j.expneurol.2026.115764_bb0525","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2014.12.035","article-title":"Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson\u2019s disease","volume":"281","author":"Liu","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0530","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2015.08.006","article-title":"Transforming growth factor-\u03921 acts via T\u03b2R-I on microglia to protect against MPP+-induced dopaminergic neuronal loss","volume":"51","author":"Liu","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0535","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-019-02037-5","article-title":"Oral and intravenous transmission of \u03b1-Synuclein fibrils to mice","volume":"138","author":"Lohmann","year":"2019","journal-title":"Acta Neuropathologica (Germany)"},{"issue":"8","key":"10.1016\/j.expneurol.2026.115764_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183090","article-title":"Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases","volume":"12","author":"L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0545","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12031-018-1162-7","article-title":"HIF-1\u03b1\/Beclin1-mediated autophagy is involved in neuroprotection induced by hypoxic preconditioning","volume":"66","author":"Lu","year":"2018","journal-title":"J. Mol. Neurosci."},{"issue":"37","key":"10.1016\/j.expneurol.2026.115764_bb0550","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1523\/JNEUROSCI.0625-19.2019","article-title":"Akt phosphorylates NQO1 and triggers its degradation, abolishing its antioxidative activities in Parkinson\u2019s disease","volume":"39","author":"Luo","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115764_bb0555","series-title":"Global, Regional, National Epidemiology and Trends of Parkinson\u2019s Disease from 1990 to 2021: Findings from the Global Burden of Disease Study 2021","author":"Luo","year":"2025"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0560","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12602-021-09828-x","article-title":"Lactiplantibacillus plantarum PS128 alleviates exaggerated cortical beta oscillations and motor deficits in the 6-Hydroxydopamine rat model of Parkinson\u2019s disease","volume":"15","author":"Ma","year":"2021","journal-title":"Probiotics Antimicrobial Proteins"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115764_bb0565","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/ijms19061637","article-title":"Use of curcumin, a natural polyphenol for targeting molecular pathways in treating age-related neurodegenerative diseases","volume":"19","author":"Maiti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2026.115764_bb0570","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-019-02896-0","article-title":"Initiation and transmission of \u03b1-synuclein pathology in Parkinson\u2019s disease","author":"Mazurskyy","year":"2019","journal-title":"Neurochem. Res. (U. S.)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0575","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson\u2019s disease - lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener. (Engl.)"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1574","article-title":"Effect of parkin on methamphetamine-induced \u03b1-synuclein degradation dysfunction in vitro and in vivo","volume":"10","author":"Meng","year":"2020","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0585","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab247","article-title":"Viral alpha-synuclein knockdown prevents spreading synucleinopathy","volume":"3","author":"Menon","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.expneurol.2026.115764_bb0590","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nbd.2018.04.008","article-title":"Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson\u2019s disease","volume":"115","author":"Miranda","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115764_bb0595","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s10571-021-01128-w","article-title":"Probiotics and the treatment of Parkinson\u2019s disease: an update","volume":"42","author":"Mirzaei","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0600","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cns.12200","article-title":"Heat shock protein 70 reduces \u03b1-synuclein-induced predegenerative neuronal dystrophy in the \u03b1-Synuclein viral gene transfer rat model of Parkinson\u2019s disease","volume":"20","author":"Moloney","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0605","article-title":"Therapeutic effect of non-invasive vagus nerve stimulation in gait disturbance and freezing in Parkinson\u2019s disease patients","volume":"46","author":"Mondal","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0610","article-title":"From the gut to the brain: the role of enteric glial cells and their involvement in the pathogenesis of Parkinson\u2019s disease","volume":"25","author":"Montalb\u00e1n-Rodr\u00edguez","year":"2024","journal-title":"Int. J. Mol. Sci. (Switzerland)"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0615","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota-brain axis in behaviour and brain disorders","volume":"19","author":"Morais","year":"2021","journal-title":"Nat. Rev. Microbiol. (Engl.)"},{"issue":"37","key":"10.1016\/j.expneurol.2026.115764_bb0620","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson\u2019s disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115764_bb0625","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/14737175.2019.1656067","article-title":"Treatment options for postural instability and gait difficulties in Parkinson\u2019s disease","volume":"19","author":"M\u00fcller","year":"2019","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.expneurol.2026.115764_bb0630","article-title":"Microglia in neuroinflammation and neurodegeneration: from understanding to therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci. (Switzerland)"},{"issue":"October","key":"10.1016\/j.expneurol.2026.115764_bb0635","article-title":"An interactive review on the role of tocotrienols in the neurodegenerative disorders","volume":"8","author":"Naomi","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.expneurol.2026.115764_bb0640","author":"National Institutes of Health"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0645","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15321819.2020.1833917","article-title":"Neuroprotective effects of probiotics bacteria on animal model of Parkinson\u2019s disease induced by 6-hydroxydopamine: a behavioral, biochemical, and histological study","volume":"42","author":"Nosrani","year":"2020","journal-title":"J. Immunoass. Immunochem."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115764_bb0650","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.expneurol.2026.115764_bb0655","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/mds.26426","article-title":"Trophic factors for Parkinson\u2019s disease: to live or let die","volume":"30","author":"Olanow","year":"2015","journal-title":"Movement Disord. Offl.J. Movement Disord. Soc. (U. S.)"},{"issue":"8","key":"10.1016\/j.expneurol.2026.115764_bb0660","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.parkreldis.2015.06.005","article-title":"Early-onset parkinsonism caused by alpha-synuclein gene triplication: clinical and genetic findings in a novel family","volume":"21","author":"Olgiati","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2026.115764_bb0665","series-title":"Gut-Brain Axis: Role of Microbiota in Parkinson\u2019s Disease and Multiple Sclerosis","author":"Ortiz","year":"2019"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0670","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/j.2040-4603.2022.tb00237.x","article-title":"Structure and functions of the vagus nerve in mammals","volume":"12","author":"Ottaviani","year":"2022","journal-title":"Comprehens. Physiol. (U. S.)"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0675","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med. (U. S.)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0680","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1471-4159.2008.05589.x","article-title":"Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson\u2019s disease","volume":"107","author":"Park","year":"2008","journal-title":"J. Neurochem."},{"issue":"November","key":"10.1016\/j.expneurol.2026.115764_bb0685","article-title":"Axonal degeneration of the vagus nerve in Parkinson\u2019s disease\u2014a high-resolution ultrasound study","volume":"9","author":"Pelz","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2026.115764_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2360872","article-title":"Oxidative stress in Parkinson\u2019s disease: potential benefits of antioxidant supplementation","volume":"2020","author":"Perc\u00e1rio","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0695","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.15288","article-title":"Exosomes in Parkinson\u2019s disease","volume":"157","author":"Pinnell","year":"2021","journal-title":"J. Neurochem. (Engl.)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0700","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0705","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/08923973.2019.1650371","article-title":"The multiple roles of exosomes in Parkinson\u2019s disease: An overview","volume":"41","author":"Porro","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0710","article-title":"The regulatory role of IL-10 in neurodegenerative diseases","volume":"10","author":"Porro","year":"2020","journal-title":"Biomolecules (Switzerland)"},{"issue":"12","key":"10.1016\/j.expneurol.2026.115764_bb0715","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3390\/brainsci11121573","article-title":"The neuroprotective effects of Cannabis-derived phytocannabinoids and resveratrol in Parkinson\u2019s disease: a systematic literature review of pre-clinical studies","volume":"11","author":"Prakash","year":"2021","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0720","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jnc.13706","article-title":"Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson\u2019s disease model","volume":"138","author":"Qi","year":"2016","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0725","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7150\/ijbs.68974","article-title":"Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing arf and rho GAP adapter protein 3 expressions after nerve injury","volume":"18","author":"Qian","year":"2022","journal-title":"Int. J. Biol. Sci. (Australia)"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0730","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4103\/NRR.NRR-D-23-01766","article-title":"Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders","volume":"20","author":"Qiu","year":"2025","journal-title":"Neural Regen. Res. (India)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0735","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-43328-x","article-title":"ALK4\/5-dependent TGF-\u03b2 signaling contributes to the crosstalk between neurons and microglia following axonal lesion","volume":"9","author":"Raffo-Romero","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0740","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11064-020-03187-9","article-title":"Is gut dysbiosis an epicenter of Parkinson\u2019s disease?","volume":"46","author":"Rajput","year":"2021","journal-title":"Neurochem. Res."},{"issue":"8","key":"10.1016\/j.expneurol.2026.115764_bb0745","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat. Neurosci. (U. S.)"},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0750","doi-asserted-by":"crossref","first-page":"148157","DOI":"10.1016\/j.bbabio.2020.148157","article-title":"Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1","volume":"2020","author":"Rao","year":"1861","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0755","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/01.wnl.0000201252.57661.e1","article-title":"A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease","volume":"66","author":"Ravina","year":"2006","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.expneurol.2026.115764_bb0760","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s00018-017-2609-7","article-title":"Melatonin as a mitochondria-targeted antioxidant: one of evolutions best ideas","volume":"74","author":"Reiter","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115764_bb0765","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acschemneuro.0c00161","article-title":"First radiolabeling of a ganglioside with a positron emitting radionuclide: In vivo PET demonstrates low exposure of radiofluorinated GM1 in non-human primate brain","volume":"11","author":"Revunov","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0770","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory t cells in an animal model of Parkinson\u2019s disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0775","doi-asserted-by":"crossref","DOI":"10.1186\/1752-2897-8-15","article-title":"Vagus nerve stimulation improves coagulopathy in hemorrhagic shock: a thromboelastometric animal model study","volume":"8","author":"Rezende-Neto","year":"2014","journal-title":"J. Trauma Manag. Outcomes"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0780","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal stem cells current clinical applications: a systematic review","volume":"52","author":"Rodr\u00edguez-Fuentes","year":"2021","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0785","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/1673-5374.350193","article-title":"Combined cell-based therapy strategies for the treatment of Parkinson\u2019s disease: focus on mesenchymal stromal cells","volume":"18","author":"Rodr\u00edguez-Pallares","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115764_bb0790","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/jnc.14476","article-title":"Astrocyte truncated tropomyosin receptor kinase b mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection","volume":"146","author":"Saba","year":"2018","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0795","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12640-021-00450-x","article-title":"Neuroprotective effects of resveratrol in in vivo and in vitro experimental models of Parkinson\u2019s disease: a systematic review","volume":"40","author":"dos","year":"2022","journal-title":"Neurotox. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2026.115764_bb0800","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/ijms17060904","article-title":"Neuroprotective and therapeutic strategies against Parkinson\u2019s disease: recent perspectives","volume":"17","author":"Sarkar","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6_suppl_4","key":"10.1016\/j.expneurol.2026.115764_bb0805","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.59.6_suppl_4.S15","article-title":"Vagus nerve stimulation therapy summary: five years after FDA approval","volume":"59","author":"Schachter","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.expneurol.2026.115764_bb0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199189","article-title":"Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson\u2019s disease","volume":"13","author":"Schneider","year":"2018","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2026.115764_bb0815","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","article-title":"A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson\u2019s disease patients","volume":"324","author":"Schneider","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115764_bb0825","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","article-title":"The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s disease","volume":"23","author":"Sch\u00f6ndorf","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.115764_bb0830","series-title":"Recent Advances in Parkinson\u2019s Disease","article-title":"Innate and adaptive immune responses in Parkinson\u2019s disease","author":"Schonhoff","year":"2020"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0835","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory t cells in a model of parkinsons disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"April","key":"10.1016\/j.expneurol.2026.115764_bb0840","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2020.01.043","article-title":"Chronic infiltration of t lymphocytes into the brain in a non-human primate model of Parkinson\u2019s disease","volume":"431","author":"Seo","year":"2020","journal-title":"Neuroscience"},{"issue":"August","key":"10.1016\/j.expneurol.2026.115764_bb0845","article-title":"Protective effects of \u03b2- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson\u2019s disease","volume":"94","author":"Shan","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.expneurol.2026.115764_bb0850","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225214","article-title":"Overexpression of pink1 or parkin in indirect flight muscles promotes mitochondrial proteostasis and extends lifespan in Drosophila melanogaster","volume":"14","author":"Si","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115764_bb0855","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4103\/1673-5374.215250","article-title":"Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson\u2019s disease","volume":"12","author":"Spittau","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0860","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1039\/C9BM01602C","article-title":"Melatonin\/Polydopamine nanostructures for collective neuroprotection-based Parkinson\u2019s disease therapy","volume":"8","author":"Srivastava","year":"2020","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb0865","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.mayocp.2019.01.001","article-title":"Mesenchymal stromal cell therapies for neurodegenerative diseases","volume":"94","author":"Staff","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"March","key":"10.1016\/j.expneurol.2026.115764_bb0870","article-title":"Projections for prevalence of parkinsons disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ (Clin. Res. Ed.) (England)"},{"issue":"September","key":"10.1016\/j.expneurol.2026.115764_bb0875","article-title":"Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK\/GSK-3\u03b2\/PP2A pathway in Parkinson\u2019s disease","volume":"907","author":"Su","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.expneurol.2026.115764_bb0880","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/15548627.2015.1082020","article-title":"Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA\/\u03b1-synuclein aggregation","volume":"11","author":"Su","year":"2015","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.expneurol.2026.115764_bb0885","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.3390\/ijms22094825","article-title":"Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques","volume":"22","author":"Sucunza","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0890","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","article-title":"Gene therapy for neurodegenerative diseases","volume":"16","author":"Sudhakar","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0895","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","article-title":"Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway","volume":"91","author":"Sun","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"May","key":"10.1016\/j.expneurol.2026.115764_bb0900","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0905","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/ijms22010403","article-title":"Natural molecules and neuroprotection: kynurenic acid, pantethine and \u03b1-lipoic acid","volume":"22","author":"T\u00f3th","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/4807179","article-title":"Chronic systemic inflammation exacerbates neurotoxicity in a Parkinson\u2019s disease model","volume":"2020","author":"Ugalde-Mu\u00f1iz","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0915","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","article-title":"Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-Synuclein in rats","volume":"138","author":"Berge","year":"2019","journal-title":"Acta Neuropathologica (Germany)"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0920","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2019","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0925","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0930","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/cells8020118","article-title":"Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson\u2019s disease?","volume":"8","author":"Vila\u00e7a-Faria","year":"2019","journal-title":"Cells"},{"issue":"November","key":"10.1016\/j.expneurol.2026.115764_bb0935","article-title":"Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson\u2019s disease model","volume":"79\u201380","author":"Vis\u00f1uk","year":"2020","journal-title":"Nutrition"},{"issue":"September","key":"10.1016\/j.expneurol.2026.115764_bb0940","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuroscience.2019.06.038","article-title":"Minocycline preserves the integrity and permeability of BBB by altering the activity of DKK1\u2013Wnt signaling in ICH model","volume":"415","author":"Wang","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb0945","article-title":"A richer and more diverse future for microglia phenotypes","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon (England)"},{"issue":"March","key":"10.1016\/j.expneurol.2026.115764_bb0950","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuro.2021.01.002","article-title":"Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson\u2019s disease model through inhibition of microglial activation","volume":"83","author":"Wang","year":"2021","journal-title":"NeuroToxicology"},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0955","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neulet.2007.06.029","article-title":"Effect of transplantation of c17.2 cells transfected with interleukin-10 gene on intracerebral immune response in rat model of Parkinson\u2019s disease","volume":"423","author":"Wang","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb0960","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.24436","article-title":"Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double-blind, randomized, controlled trial","volume":"78","author":"Warren Olanow","year":"2015","journal-title":"Ann. Neurol. (U. S.)"},{"issue":"13","key":"10.1016\/j.expneurol.2026.115764_bb0965","article-title":"Microglia phenotypes in aging and neurodegenerative diseases","volume":"11","author":"Wendimu","year":"2022","journal-title":"Cells (Switzerland)"},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb0970","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 t cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115764_bb0975","doi-asserted-by":"crossref","first-page":"1308577","DOI":"10.3389\/fnagi.2024.1308577","article-title":"Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor fasudil in patients with Parkinson\u2019s disease (ROCK-PD)","volume":"16","author":"Wolff","year":"2024","journal-title":"Front. Aging Neurosci. (Switzerland)"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb0980","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J. Neuroinflamm. (England)"},{"issue":"10","key":"10.1016\/j.expneurol.2026.115764_bb0985","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with parkinsons disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"48","key":"10.1016\/j.expneurol.2026.115764_bb0990","doi-asserted-by":"crossref","first-page":"11701","DOI":"10.1523\/JNEUROSCI.1799-17.2017","article-title":"Autocrine interleukin-10 mediates glucagon-like peptide-1 receptor-induced spinal microglial \u03b2-endorphin expression","volume":"37","author":"Wu","year":"2017","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb0995","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12264-016-0092-z","article-title":"Exosomes in Parkinson\u2019s disease","volume":"33","author":"Wu","year":"2016","journal-title":"Neurosci. Bull."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb1000","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neuropharm.2009.10.009","article-title":"Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K\/Akt pathways","volume":"58","author":"Xia","year":"2010","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.expneurol.2026.115764_bb1005","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbi.2010.08.004","article-title":"IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection","volume":"25","author":"Xin","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"June","key":"10.1016\/j.expneurol.2026.115764_bb1010","article-title":"Restoration and targeting of aberrant neurotransmitters in Parkinson\u2019s disease therapeutics","volume":"156","author":"Yadav","year":"2022","journal-title":"Neurochem. Int. (England)"},{"issue":"January","key":"10.1016\/j.expneurol.2026.115764_bb1015","article-title":"Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb1020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbrc.2020.03.097","article-title":"Bruceine d elevates nrf2 activation to restrain Parkinson\u2019s disease in mice through suppressing oxidative stress and inflammatory response","volume":"526","author":"Yang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2026.115764_bb1025","article-title":"Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of alzheimer disease model mice by suppressing neuro-inflammation and glial pathology","author":"Yang","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"48","key":"10.1016\/j.expneurol.2026.115764_bb1030","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","article-title":"Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson\u2019s disease","volume":"26","author":"Yasuhara","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb1035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41420-024-01953-0","article-title":"PGC-1a mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration","volume":"10","author":"You","year":"2024","journal-title":"Cell Death Discov. (U. S.)"},{"issue":"February","key":"10.1016\/j.expneurol.2026.115764_bb1040","article-title":"Potential roles of exosomes in Parkinson\u2019s disease: from pathogenesis, diagnosis, and treatment to prognosis","volume":"8","author":"Yu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb1045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1021\/acschemneuro.8b00469","article-title":"Exosomes in Parkinson\u2019s disease: current perspectives and future challenges","volume":"10","author":"Yuan","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.expneurol.2026.115764_bb1050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of a1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med. (U. S.)"},{"key":"10.1016\/j.expneurol.2026.115764_bb1055","first-page":"1321","article-title":"Progesterone prevents impairment of cognitive, affective and motor events in a reserpine model of parkinsonism in male rats","volume":"6","author":"Yunes","year":"2022","journal-title":"Clin. Case Rep. Int."},{"issue":"2","key":"10.1016\/j.expneurol.2026.115764_bb1060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018025666","article-title":"Melatonin improves behavioral and biochemical outcomes in a rotenone-induced rat model of Parkinson\u2019s disease","volume":"37","author":"Zeeshan","year":"2018","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.115764_bb1065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2017.03.005","article-title":"Rescue of pink1 deficiency by stress-dependent activation of autophagy","volume":"24","author":"Zhang","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"S4","key":"10.1016\/j.expneurol.2026.115764_bb1070","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.S4-003","article-title":"Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson\u2019s disease","volume":"01","author":"Zhao","year":"2011","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"12","key":"10.1016\/j.expneurol.2026.115764_bb1075","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s11064-017-2388-4","article-title":"Capsaicin protects against oxidative insults and alleviates behavioral deficits in rats with 6-OHDA-induced Parkinson\u2019s disease via activation of TRPV1","volume":"42","author":"Zhao","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2026.115764_bb1080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fcell.2020.00384","article-title":"Single-cell RNA-Seq analysis uncovers distinct functional human NKT cell sub-populations in peripheral blood","volume":"8","author":"Zhou","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.115764_bb1085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.13111","article-title":"TGF\u03b21 inhibits IFN\u03b3-mediated microglia activation and protects mDA neurons from IFN\u03b3-driven neurotoxicity","volume":"134","author":"Zhou","year":"2015","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.expneurol.2026.115764_bb1090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","article-title":"Neuroprotection of fasting mimicking diet on MPTP-induced parkinsons disease mice via gut microbiota and metabolites","volume":"16","author":"Zhou","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"September","key":"10.1016\/j.expneurol.2026.115764_bb1100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.intimp.2017.07.017","article-title":"Interleukin-10 inhibits Neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway","volume":"50","author":"Zhu","year":"2017","journal-title":"Int. Immunopharmacol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:00:53Z","timestamp":1794434453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":218,"alternative-id":["S0014488626001275"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115764","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115764"}}